Taking people in Norvégia1. fázis
A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who are already scheduled for surgery for a returning glioblastoma
Key facts
- Where
- Oslo, NorvégiaSee the site
- Phase
- 1. fázis
Where in Norvégia
- Oslo Universitetssykehus HFOslo, NorvégiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oncopeptides AB
- Trial code
- EU 2026-525543-32-00
- Record updated
- 2026. május 15.